The Myeloma Beacon » Treanda (bendamustine, SDX-105)

Treanda (bendamustine, SDX-105)

By: Admin; Published: May 9, 2009 @ 10:15 pm | Comments Disabled

Brand Name:	Treanda
Generic Name:	bendamustine
Code Name:	SDX-105
Company:	Cephalon Oncology
FDA Clinical Phase:	1/2

Description:

Treanda (news articles ^[1]) is a drug that is used to treat chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma (NHL) . It is also being studied in the treatment of other types of cancer. Treanda is a type of purine analog/alkylator hybrid drug, which may damage the DNA in cancer cells and kill them.

Clinical Trials:
For a list of clinical trials studying Treanada for the treatment of multiple myeloma, see ClinicalTrials.gov ^[2].

Official website for Treanda: http://www.treanda.com/ ^[3]

Source: NCI Cancer Glossary, Treanda, http://www.cancer.gov/dictionary/?searchTxt=treanda ^[4] (as of November 14, 2009)

Article printed from The Myeloma Beacon: https://myelomabeacon.org

URL to article: https://myelomabeacon.org/resources/2009/05/09/treanda/

URLs in this post:

[1] news articles: https://myelomabeacon.org/tag/treanda/

[2] ClinicalTrials.gov: http://clinicaltrials.gov/ct2/results?term=&recr=&rslt=&type=&cond=multiple+myeloma&intr=Treanda&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=

[3] http://www.treanda.com/: http://www.treanda.com/

[4] http://www.cancer.gov/dictionary/?searchTxt=treanda: http://www.cancer.gov/dictionary/?searchTxt=treanda

Click here to print.